In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Body-based burial: Students imagine urns made from blood and hair
In Slovenia, students at University of Ljubljana have used biobased materials for a variety of design projects, including a biodegradable urn made of blood...
Uttar Pradesh eyes cow poop plastics to boost rural economy
In Uttar Pradesh, a government project is collecting cow dung to convert into usable products such as bioplastics, textiles, and paper.
The Press Trust...
Luxury brand Velvet Eyewear lauds advances in biobased acetate
In California, luxury women’s eyewear brand Velvet Eyewear has unveiled its first biobased eyewear collection.
Crafted from renewable sources like wood pulp and cotton...